ENTYVIO in Bio-naive Patients With Moderate/Severe Crohn's Disease (CD) in Daily Practice

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

September 30, 2020

Primary Completion Date

November 30, 2022

Study Completion Date

November 30, 2022

Conditions
Crohn Disease
Trial Locations (14)

V1Y 6J6

Kelowna GI Associates, Kelowna

V3L 3W4

Fraser Clinical Trials Inc., New Westminster

R3C 0N2

The Winnipeg Clinic, Winnipeg

E3B 4R3

REGIONAL HEALTH AUTHORITY B doing business as HORIZON HEALTH NETWORK, Fredericton

B3V 1V7

Nova ScotiaHealth Authority, Halifax

L4M 7G1

Barrie GI Associates, Barrie

N6C 2R5

Lawson Health Research Institute a joint venture of London Health Science Centre Research Inc., Lawson Research Institute., London

L6H 7v7

Girish Bajaj MPC, Oakville

M5G 1X5

Sinai Health System, Toronto

M5T 3A9

Kensington Cancer Screening Clinic, Toronto

M6A 3B4

Toronto Immune and Digestive Health Institute, Toronto

H3G 1A4

Research Institute McGill University Health Centre (RI-MUHC), Montreal

J1G 2E8

Centre integre universitaire de sante et de services sociaux de l'Estrie Centre hospitalier universitaire de Sherbrooke, Sherbrooke

S7N 0W8

University of Saskatchewan, Saskatoon

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY